AZURAJAY Trademark

Trademark Overview


On Wednesday, January 10, 2024, a trademark application was filed for AZURAJAY with the United States Patent and Trademark Office. The USPTO has given the AZURAJAY trademark a serial number of 98350774. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, July 1, 2024. This trademark is owned by Bristol-Myers Squibb Company. The AZURAJAY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and biological preparations for human use.
azurajay

General Information


Serial Number98350774
Word MarkAZURAJAY
Filing DateWednesday, January 10, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateMonday, July 1, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical and biological preparations for human use.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 10, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08543

Trademark Events


Event DateEvent Description
Wednesday, January 10, 2024NEW APPLICATION ENTERED
Monday, April 29, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 27, 2024ASSIGNED TO EXAMINER
Monday, July 1, 2024NON-FINAL ACTION E-MAILED
Monday, July 1, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 1, 2024NON-FINAL ACTION WRITTEN